FRESENIUS MEDICAL CARE-ADR (FMS) Stock News

USA - NYSE:FMS - US3580291066 - ADR

26.84 USD

+0.16 (+0.6%)

Last: 10/31/2025, 8:04:00 PM

26.84 USD

0 (0%)

After Hours: 10/31/2025, 8:04:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

FMS Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Zacks Investment Research - Mentions: CVS

CVS vs. FMS: Which Healthcare Services Stock Has More Upside?

8 days ago - By: Zacks Investment Research - Mentions: MASI MMSI WST

Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now

a month ago - By: Zacks Investment Research

Why Fresenius (FMS) is a Top Momentum Stock for the Long-Term

2 months ago - By: Zacks Investment Research

Are Options Traders Betting on a Big Move in Fresenius Medical Stock?

2 months ago - By: Benzinga - Mentions: NEM FTNT PFGC CRWV ...

This Fortinet Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday

3 months ago - By: Benzinga - Mentions: AMPH VTRS

Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum

3 months ago - By: Zacks Investment Research

Here's Why Fresenius (FMS) is a Strong Value Stock

4 months ago - By: Zacks Investment Research - Mentions: HRTG EGO HOPE

4 High Earnings Yield Value Stocks You Should be Owning

3 months ago - By: Yahoo Finance - Mentions: AMPH VTRS

Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum

3 months ago - By: Zacks Investment Research - Mentions: THC WST EHC

Encompass Health Q2 Earnings Beat Estimates, Stock Up 7.4%

3 months ago - By: Zacks Investment Research - Mentions: THC WST SEM

Select Medical Shares Down 20% Despite Q2 Earnings Beat

3 months ago - By: Zacks Investment Research - Mentions: WST TDOC DOCS

Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses

5 months ago - By: Zacks Investment Research

Fresenius (FMS) Upgraded to Buy: Here's Why

6 months ago - By: Zacks Investment Research

Fresenius (FMS) is a Great Momentum Stock: Should You Buy?

3 months ago - By: Zacks Investment Research - Mentions: UNH WST DOCS

UnitedHealth Q2 Earnings Miss Estimates on Increasing Medical Costs

3 months ago - By: Zacks Investment Research - Mentions: UHS WST DOCS

Universal Health Q2 Earnings Beat on Strong Acute Care Admissions

4 months ago - By: Zacks Investment Research - Mentions: PAHC EHC NVST

Encompass Health Opens Rehabilitation Hospital in Florida

4 months ago - By: Yahoo Finance - Mentions: GS VZ

Fresenius Medical Care AG (FMS) Partners With Mexico’s Coordination of National Institutes of Health and Specialty Hospitals

4 months ago - By: Zacks Investment Research - Mentions: HRTG EGO HOPE

Zacks.com featured highlights Fresenius Medical Care, Eldorado Gold, Hope Bancorp and Heritage Insurance

6 months ago - By: Zacks Investment Research - Mentions: BCRX WYY CBNA

New Strong Buy Stocks for May 9th

6 months ago - By: Zacks Investment Research

Best Value Stocks to Buy for May 9th

6 months ago - By: Zacks Investment Research

Best Income Stocks to Buy for May 9th

5 months ago - By: Zacks Investment Research - Mentions: ANGO CVS ITGR

Reasons to Add Fresenius Medical Stock to Your Portfolio Now

5 months ago - By: Zacks Investment Research

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

5 months ago - By: Zacks Investment Research - Mentions: HOLX DGX

HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick?

5 months ago - By: Zacks Investment Research

Here's Why Fresenius (FMS) is a Strong Value Stock

6 months ago - By: Zacks Investment Research

Fresenius (FMS) is a Top-Ranked Momentum Stock: Should You Buy?

6 months ago - By: Zacks Investment Research - Mentions: DXCM IDXX CLPT NPCE

5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil

6 months ago - By: Zacks Investment Research - Mentions: BSX CVS ITGR

FMS Stock Up as Q1 Earnings Beat Estimates, Revenues Up Y/Y

6 months ago - By: Zacks Investment Research

Why Fresenius (FMS) is a Top Value Stock for the Long-Term

6 months ago - By: Zacks Investment Research - Mentions: MASI CLOV

Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?

6 months ago - By: Zacks Investment Research - Mentions: BAX MASI AHCO

BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y